Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Amneal Pharmaceuticals, Inc. company logo
Amneal Pharmaceuticals, Inc. logo

Amneal Pharmaceuticals, Inc. (AMRX)

Profile

Company profile for Amneal Pharmaceuticals, Inc. (AMRX)
MetricValue
Full NameAmneal Pharmaceuticals, Inc.
TickerNASDAQ: AMRX
ExchangeNASDAQ
SectorHealthcare
IndustrySpecialty & Generic Drug Manufacturers
CountryUnited States
IPO
IndexesNot included
Websiteamneal.com
Employees8,300

Key Metrics

Amneal Pharmaceuticals, Inc. Key Details
MetricDateValue
Price$12.71
Price, 1D Change+0.39%
Market Cap$4B
-
PE Ratio901.42
Beta0.87
Revenue$3B
Revenue, 1Y Change+16.73%
EPS-$0.38
EPS, 1Y Change+20.68%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Amneal Pharmaceuticals, Inc. chart

Events

Amneal Pharmaceuticals, Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

AMRX Estimates
MetricDateValue
EPS-$0.38
EPS Estimate$0.80
EPS Est. Change+311.08%
Revenue$2.79B
Revenue Estimate$3.01B
Revenue Est. Change+7.83%
Current Price$12.71
Price Target-$14.00
Price Tgt. Change-+10.15%

🔒 Log In To Unlock Full Data

EPS

AMRX EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
$0.59-$0.48-180.83%
$0.61-$0.38-161.78%
$0.80N/A+311.08%
$0.93N/A+344.94%
AMRX EPS reported versus estimate values chart

Revenue

AMRX revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$2.41B$2.39B-0.71%
$2.77B$2.79B+0.81%
$3.01BN/A+7.83%
$3.21BN/A+15.02%
AMRX revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

AMRX Performance
MetricDateValue
Price, 1Y+62.53%
Price, 3Y+480.37%
Market Cap, 1Y+64.88%
Market Cap, 3Y+1,104.34%
Revenue, 1Y+16.73%
Revenue, 3Y+33.45%
EPS, 1Y+20.68%
EPS, 3Y-640.43%

🔒 Log In To Unlock Full Data

Technical Indicators

AMRX Technical Indicators
MetricDateValue
Current Price$12.71
SMA 200$9.34
SMA 200 vs Price-26.52%
SMA 50$11.90
SMA 50 vs Price-6.40%
Beta0.87
ATR$0.31
14-Day RSI58.82
10-Day Volatility16.67%
1-Year Volatility33.43%

Dividends

AMRX Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
Dividends Paid$0.00
Payout Ratio0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

AMRX Income & Profitability
MetricDateValue
Revenue$2.79B
EPS-$0.38
Gross Profit$1.02B
Gross Margin36.52%
Operating Profit$353.29M
Operating Margin-50.83%
Net Income-$73.88M
Net Margin-2.64%
EBITDA$589.48M

🔒 Log In To Unlock Full Data

Financial Health

AMRX Financial Health
MetricDateValue
Debt To Equity-23.73
Current Ratio1.41
Quick Ratio0.86
-
F-Score6
Altman Z-Score1.72

Valuations

AMRX Valuations
MetricDateValue
PE Ratio901.42
PS Ratio1.36
PB Ratio-36.50
EV/EBITDA10.66
Enterprise ValueN/A-

Balance Sheet

AMRX Balance Sheet
MetricDateValue
Book Value-$109.27M
Cash & Equivalents$118.42M
Total Assets$3.50B
Current Assets$1.59B
Total Liabilities$3.55B
Current Liabilities$1.13B
Total Debt$2.59B
Short Term Debt$340.26M
Accounts Payable$258.69M

Expenses

AMRX Expenses
MetricDateValue
Total Expenses$2.91B
Operating Expenses$667.15M
Cost Of Goods Sold$1.77B
SG&A$0.00
D&A$236.19M
Interest Expense$0.00
Income Tax$18.86M

Cash Flow

AMRX Cash Flow
MetricDateValue
CFO$295.03M
CFI-$63.00M
CFF-$211.72M
Capex$74.99M
Free Cash Flow$220.04M

Recent analyst updates

AMRX Recent analyst updates
MetricDateValue
Barclays
Piper Sandler→
JP Morgan→
Barclays→
JP Morgan→
Piper Sandler→
Truist Securities→
JP Morgan→
Barclays→
Truist Securities→

Analyst sentiment

Sentiment over the past month
AMRX analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
AMRX institutional ownership distribution chart

Screeners with AMRX

Data Sources & References

  1. AMRX Official Website www.amneal.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1723128/000172312825000059/0001723128-25-000059-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1723128/000172312825000012/0001723128-25-000012-index.htm
  4. AMRX Profile on Yahoo Finance finance.yahoo.com/quote/AMRX
  5. AMRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/amrx

FAQ

  • What is the ticker symbol for Amneal Pharmaceuticals, Inc.?

    The ticker symbol for Amneal Pharmaceuticals, Inc. is NASDAQ:AMRX

  • Does Amneal Pharmaceuticals, Inc. pay dividends?

    No, Amneal Pharmaceuticals, Inc. does not pay dividends

  • What sector is Amneal Pharmaceuticals, Inc. in?

    Amneal Pharmaceuticals, Inc. is in the Healthcare sector

  • What industry is Amneal Pharmaceuticals, Inc. in?

    Amneal Pharmaceuticals, Inc. is in the Specialty & Generic Drug Manufacturers industry

  • What country is Amneal Pharmaceuticals, Inc. based in?

    Amneal Pharmaceuticals, Inc. is headquartered in United States

  • When did Amneal Pharmaceuticals, Inc. go public?

    Amneal Pharmaceuticals, Inc. initial public offering (IPO) was on May 7, 2018

  • Is Amneal Pharmaceuticals, Inc. in the S&P 500?

    No, Amneal Pharmaceuticals, Inc. is not included in the S&P 500 index

  • Is Amneal Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Amneal Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

  • Is Amneal Pharmaceuticals, Inc. in the Dow Jones?

    No, Amneal Pharmaceuticals, Inc. is not included in the Dow Jones index

  • When was Amneal Pharmaceuticals, Inc. last earnings report?

    Amneal Pharmaceuticals, Inc.'s most recent earnings report was on October 30, 2025

  • When does Amneal Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Amneal Pharmaceuticals, Inc. is February 27, 2026